Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SLQT
SLQT logo

SLQT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.660
Open
0.634
VWAP
0.61
Vol
1.13M
Mkt Cap
104.50M
Low
0.562
Amount
684.25K
EV/EBITDA(TTM)
11.96
Total Shares
176.29M
EV
748.08M
EV/OCF(TTM)
61.99
P/S(TTM)
0.07
SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.
Show More

Events Timeline

(ET)
2026-03-25
16:20:00
SelectQuote Faces NYSE Compliance Issue as Stock Price Falls Below $1
select
2026-01-15 (ET)
2026-01-15
07:10:00
SelectQuote Reaches New Agreement with Long-Time PBM Partner
select
2025-08-21 (ET)
2025-08-21
07:37:32
SelectQuote Announces Q4 EPS of 2 Cents, Below Consensus Estimate of 13 Cents
select
2025-07-02 (ET)
2025-07-02
16:16:03
SelectQuote vice chairman Tom Grant passes away
select
2025-05-12 (ET)
2025-05-12
07:36:04
SelectQuote sees FY25 revenue $1.5B-$1.575B, consensus $1.53B
select
2025-05-12
07:35:24
SelectQuote reports Q3 EPS 3c vs 5c last year
select
2025-05-09 (ET)
2025-05-09
08:04:34
SelectQuote responds to allegations in DOJ complaint
select

News

seekingalpha
8.5
03-25seekingalpha
SelectQuote Faces Delisting Risk as Share Price Falls Below $1
  • Delisting Notice: SelectQuote received a notice from the New York Stock Exchange for failing to meet continued listing standards as its average share price fell below $1 for 30 consecutive trading days, indicating poor market performance that could undermine investor confidence.
  • Compliance Plan: The company intends to regain compliance within the six-month cure period by lifting its share price, demonstrating its commitment to adhering to market regulations and rebuilding investor trust.
  • Trading Continuity: Despite the delisting risk, SelectQuote stated that its stock will continue to trade on the NYSE during the cure period, indicating the company's efforts to maintain market activity and liquidity.
  • Future Outlook: SelectQuote is also facing a $40 million financial headwind and has lowered its 2026 guidance, although it targets a 20%+ EBITDA margin and $25–35 million in operating cash flow, reflecting strategic goals amid adversity.
PRnewswire
7.0
03-18PRnewswire
SelectQuote Executives Allegedly Breached Fiduciary Duties
  • Legal Investigation Launched: Kuehn Law, PLLC is investigating whether SelectQuote, Inc. executives breached their fiduciary duties to shareholders, with allegations including failure to disclose the company's direction of Medicare beneficiaries to unsuitable insurance plans, potentially harming shareholder interests.
  • Misconduct Allegations: The lawsuit claims that SelectQuote improperly steered Medicare beneficiaries towards certain insurers while receiving illegal kickbacks, indicating serious compliance issues that could expose the company to legal sanctions.
  • Increased Compliance Risks: SelectQuote's failure to adhere to applicable laws and regulations may lead to regulatory and legal sanctions, particularly concerning potential violations of the False Claims Act, which could negatively impact the company's reputation and financial health.
  • Shareholder Interests at Risk: The executives' actions have resulted in materially misleading positive statements about the company's business prospects, putting shareholders at risk of investment losses, prompting Kuehn Law to urge affected shareholders to contact them promptly to protect their rights.
Newsfilter
7.0
03-18Newsfilter
SelectQuote Executives Allegedly Breached Fiduciary Duties
  • Legal Investigation Initiated: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations including the failure to disclose the company's practice of directing Medicare beneficiaries to unsuitable insurance plans, harming shareholder interests.
  • False Statement Allegations: According to a federal securities lawsuit, SelectQuote is accused of failing to provide unbiased comparisons of Medicare Advantage plans and prioritizing its own interests when recommending insurers, potentially facing legal and regulatory sanctions.
  • Illegal Kickback Issues: SelectQuote is alleged to have accepted illegal kickbacks to steer Medicare beneficiaries towards specific insurers, thereby limiting enrollment in competitors' plans, which severely impacts the company's compliance and reputation.
  • Potential Legal Consequences: Due to these actions, SelectQuote may have violated the False Claims Act, and positive statements regarding the company's operations and prospects are deemed misleading, potentially exposing shareholders to significant financial risks.
Newsfilter
8.5
03-17Newsfilter
SelectQuote Launches Local Franchise Initiative to Expand Insurance Distribution
  • Franchise Expansion: SelectQuote has launched the SelectQuote Local initiative, leveraging its industry-leading marketing and technology capabilities to offer Medicare insurance products through a franchise model, thereby enhancing consumer engagement and expanding market share.
  • Business Growth Opportunity: Franchise owners can purchase rights to operate in specific regions, providing them with an attractive business opportunity while creating new growth potential for SelectQuote, which is expected to enhance the company's competitiveness in the Medicare insurance sector.
  • Financial Benefits: SelectQuote Local is anticipated to drive scale in the insurance distribution business with low capital investment, generating recurring royalty income that enhances cash returns for shareholders, while complementing the growth of the SelectRx pharmacy business.
  • Market Positioning Advantage: With over four decades of experience in insurance brokerage, SelectQuote has optimized its marketing and customer service, and the launch of SelectQuote Local will further solidify its leadership position in the Medicare insurance market, addressing the growing demand for senior insurance products.
seekingalpha
9.5
02-05seekingalpha
SelectQuote Reports Strong Q2 2026 Earnings Amid Guidance Cuts
  • Strong Financial Performance: SelectQuote reported Q2 revenue of $537 million, a 12% year-over-year increase, with the Healthcare Services segment growing 26%, reflecting robust demand and execution in the senior market.
  • Record EBITDA Margins: The company achieved a near-record EBITDA margin of 39% in its Senior division, despite facing budget cuts from PBM and carrier partners, indicating strong profitability resilience.
  • Credit Facility Expansion: SelectQuote announced a new $415 million credit facility extending debt maturities to 2031, providing greater financial flexibility to support ongoing profitable growth initiatives.
  • Revised Financial Guidance: While management remains confident in long-term targets, the fiscal 2026 revenue guidance has been lowered to a range of $1.61 billion to $1.71 billion due to PBM and carrier budget cuts, highlighting short-term market challenges.
seekingalpha
9.5
02-05seekingalpha
SelectQuote Q2 Earnings Exceed Expectations
  • Earnings Beat: SelectQuote reported Q2 GAAP EPS of $0.26, exceeding expectations by $0.05, indicating strong profitability and boosting investor confidence in the company's financial health.
  • Revenue Growth: The company achieved revenue of $537.1 million, an 11.6% year-over-year increase, surpassing market expectations by $6.37 million, reflecting SelectQuote's competitive position and driving overall business growth.
  • Future Guidance: SelectQuote's guidance for fiscal year 2026 projects revenue between $1.61 billion and $1.71 billion, with adjusted EBITDA expected to range from $90 million to $100 million, showcasing the company's confidence in future growth and strategic planning.
  • Financing Support: The company secured a $415 million credit facility, extending debt maturity to 2031, which will provide greater financial flexibility and support its long-term growth strategy.
Wall Street analysts forecast SLQT stock price to rise
3 Analyst Rating
Wall Street analysts forecast SLQT stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Noble Capital
Outperform
downgrade
$7 -> $5
AI Analysis
2026-02-06
Reason
Noble Capital
Price Target
$7 -> $5
AI Analysis
2026-02-06
downgrade
Outperform
Reason
Noble Capital lowered the firm's price target on SelectQuote to $5 from $7 and keeps an Outperform rating on the shares to reflect updated forecasts and heightened near-term uncertainty following the company's fiscal Q2 report.
Craig-Hallum
Buy
downgrade
$4 -> $3
2026-02-06
Reason
Craig-Hallum
Price Target
$4 -> $3
2026-02-06
downgrade
Buy
Reason
Craig-Hallum lowered the firm's price target on SelectQuote to $3 from $4 and keeps a Buy rating on the shares. The firm notes the company reported Q2 results that were modestly ahead of estimates but lowered the full year guide.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SLQT
Unlock Now

Valuation Metrics

The current forward P/E ratio for SelectQuote Inc (SLQT.N) is 66.67, compared to its 5-year average forward P/E of -4.66. For a more detailed relative valuation and DCF analysis to assess SelectQuote Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-4.66
Current PE
66.67
Overvalued PE
35.65
Undervalued PE
-44.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.18
Current EV/EBITDA
2.06
Overvalued EV/EBITDA
53.62
Undervalued EV/EBITDA
-51.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.63
Current PS
0.06
Overvalued PS
1.55
Undervalued PS
-0.28

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

lowest share costing stocks
Intellectia · 53 candidates
Market Cap: >= 50.00MRegion: USPrice: <= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
KALA logo
KALA
KALA BIO Inc
195.30M
MREO logo
MREO
Mereo BioPharma Group PLC
55.83M
SGMO logo
SGMO
Sangamo Therapeutics Inc
130.65M
OPTT logo
OPTT
Ocean Power Technologies Inc
86.12M
IMMP logo
IMMP
Immutep Ltd
54.23M
GOSS logo
GOSS
Gossamer Bio Inc
89.54M
what should I buy under 1.00 a share?
Intellectia · 344 candidates
Price: $0.10 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
ALIT logo
ALIT
Alight Inc
507.72M
UP logo
UP
Wheels Up Experience Inc
406.86M
LAB logo
LAB
Standard BioTools Inc
392.26M
GETY logo
GETY
Getty Images Holdings Inc
360.43M
BYND logo
BYND
Beyond Meat Inc
352.61M
CAN logo
CAN
Canaan Inc
345.29M
pennystocks
Intellectia · 37 candidates
Market Cap: <= 300.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $10.00
Ticker
Name
Market Cap$
top bottom
ASPN logo
ASPN
Aspen Aerogels Inc
295.88M
SLQT logo
SLQT
SelectQuote Inc
283.31M
STTK logo
STTK
Shattuck Labs Inc
280.96M
AVIR logo
AVIR
Atea Pharmaceuticals Inc
275.01M
JELD logo
JELD
JELD-WEN Holding Inc
258.00M
TYGO logo
TYGO
Tigo Energy Inc
243.42M
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M
Best stock under 3.50 that will 3x
Intellectia · 29 candidates
Market Cap: <= 2.00BPrice: <= $3.50Beta: HighRiskRevenue 5yr Cagr: >= 20Annual Eps Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
CLVT logo
CLVT
Clarivate PLC
1.86B
BITF logo
BITF
Bitfarms Ltd
1.61B
BLND logo
BLND
Blend Labs Inc
732.49M
SNDL logo
SNDL
SNDL Inc
406.85M
LCTX logo
LCTX
Lineage Cell Therapeutics Inc
382.34M
SLQT logo
SLQT
SelectQuote Inc
283.31M

Whales Holding SLQT

A
Abrams Bison Investments, L.L.C.
Holding
SLQT
+5.17%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SelectQuote Inc (SLQT) stock price today?

The current price of SLQT is 0.5928 USD — it has decreased -5.88

What is SelectQuote Inc (SLQT)'s business?

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

What is the price predicton of SLQT Stock?

Wall Street analysts forecast SLQT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLQT is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SelectQuote Inc (SLQT)'s revenue for the last quarter?

SelectQuote Inc revenue for the last quarter amounts to 537.10M USD, increased 11.65

What is SelectQuote Inc (SLQT)'s earnings per share (EPS) for the last quarter?

SelectQuote Inc. EPS for the last quarter amounts to 0.27 USD, decreased -10.00

How many employees does SelectQuote Inc (SLQT). have?

SelectQuote Inc (SLQT) has 1181 emplpoyees as of April 02 2026.

What is SelectQuote Inc (SLQT) market cap?

Today SLQT has the market capitalization of 104.50M USD.